Loading data
SFHGNasdaq
| Unit: USD | FY2025 | FY2024 |
|---|---|---|
| Cost of revenue | 17.31 m USD | 15.21 m USD |
| Gross profit | 4.5 m USD | 4.55 m USD |
| Research and development expense | 828.67 k USD | 584.14 k USD |
| Operating profit | -2.77 m USD | -297.43 k USD |
| Profit before tax | -2.51 m USD | -223.22 k USD |
| Income tax expense | 34.48 k USD | 119.28 k USD |
| Net income (reported basis) | -2.55 m USD | -342.49 k USD |
| Basic earnings per share | -0.13 USD/share | -0.02 USD/share |
| Diluted earnings per share | -0.13 USD/share | -0.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.